Clinical trials of WR-2721 prior to alkylating agent chemotherapy and radiotherapy.
Glover
D
D
Department of Medicine, University of Pennsylvania, Philadelphia 19104.
Fox
K R
KR
Weiler
C
C
Kligerman
M M
MM
Turrisi
A
A
Glick
J H
JH
D000477:Alkylating Agents / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D004999:Amifostine / Q000627:therapeutic use*; D002945:Cisplatin / Q000037:antagonists & inhibitors; D003520:Cyclophosphamide / Q000037:antagonists & inhibitors; D004341:Drug Evaluation; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D009946:Organothiophosphorus Compounds / Q000627:therapeutic use*; D011832:Radiation Injuries / Q000517:prevention & control
D000477:Alkylating Agents; D009946:Organothiophosphorus Compounds; D003520:Cyclophosphamide; D004999:Amifostine; D002945:Cisplatin